A national education program for pharmacists funded by the Australian Government under the Quality Use of Diagnostics, Therapeutics and Pathology program.[/caption]
While the evidence bases for both CMs and Schedule 3 sleep aids are unlikely to immediately change, a core practice consideration is the risk-benefit profile of the respective non-prescription sleep aids for the individual patient. 
Is it really insomnia?
Knowledge to practice 
From the President: What opportunities have been unlocked?
PSA’s flagship plan Pharmacists in 2023 outlines system changes needed to unlock opportunities for pharmacists to be the best they can be.
Children’s vaccinations
In recent years jurisdictional regulations have been amended enabling Australian pharmacists to administer some vaccines to children.
Culture well
Community pharmacists and Arabic speaking Australians – communicating capably to build health partnerships.
Pharmacists as pastoral carers in cognitive decline
The pastoral care role of the community pharmacist means we can still provide positive guidance even when medications will be generally ineffective.
Pharmacists working in...
Communicating safely
Instilling quality and safety into conversations around the provision of Pharmacist Only medicines.
Effective provision of Pharmacist Only medicines requires a thorough understanding of a...
